E-Care Acceptability for Older People Undergoing Chemotherapy

Not Applicable

Withdrawn

• Conditions: Cancer
• Interventions: Device: CHATBOT use

• Registration Number: NCT05408195
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

The main objective of this pilot study is to evaluate the acceptability of clinical data collection using a semi-automated e-solution based on the use of text messaging among older adults undergoing chemotherapy treatment at home.

Detailed Description

Most cancer diagnosis are made among the 70 years and over population. In this population, negative consequences of cancer treatments are of great concern, especially for those who are socially isolated or live in rural areas. International oncology societies recommend personalized treatments to reduce adverse events. However, few tools have been validated in this population to monitor compliance and risks of outpatient treatments. In addition, health professionals continue to manage unplanned patient calls which could disrupt effectiveness of their work. Our hypothesis is that the semi-automated collection of health data (text message questionnaires) during outpatient chemotherapy secures the patient's care pathway and optimizes care time, in particular for patients' education and support. Therefore, patients (and/or their caregivers) who benefit from calls follow-up (usual care), would have the possibility of receiving an additional weekly remote questionnaire (by email or SMS) via a CHATBOT on any terminal. This automated questionnaire collects data on tolerance and compliance with care plan.

Study Timeline

• Study First Submitted: 2022-05-24
• Study First Submitted QC: 2022-06-02
• Study First Posted: 2022-06-07
• Study Start: 2024-01-01
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-27
• Last Update Posted: 2024-06-28
• Primary Completion: 2025-01-01
• Study Completion: 2025-01-01

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Subjects of 70 years of age or older;
• Subjects undergoing chemotherapy treatment after a cancer diagnosis;
• Subjects managed by the oncogeriatrics team at the Toulouse University Hospital as part of an outpatient follow-up and followed by conventional telephone calls and CHATBOT support.

Exclusion Criteria

• Patient's refusal to participate.
• Patient does not have sufficient equipment for downloading and using the CHATBOT tool
• Participant under guardianship, curatorship or safeguard of justice.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
CHATBOT users	CHATBOT use	patients downloading and using the CHATBOT

Primary Outcome Measures

Name	Time	Method
Acceptance of semi-automated follow-up	6 months of CHATBOT use	Proportion of patients who uploaded the application, Proportion of patients who received at least one questionnaire, Proportion of patients who answered at least one questionnaire, Completion questionnaire rate and answered questionnaire rate

Trial Locations

Locations (1)

CHU de Toulouse; 🇫🇷 Toulouse, France